Archives of Clinical Infectious Diseases

Published by: Neoscriber Demo Publisher

Detection of Genes Involved in Biofilm Formation in MDR and XDR Acinetobacter baumannii Isolated from Human Clinical Specimens in Isfahan, Iran

Ahad Mahmoudi Monfared 1 , Aliakbar Rezaei 1 , Farkhondeh Poursina 1 and Jamshid Faghri 1 , *
Authors Information
1 Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Archives of Clinical Infectious Diseases: 14 (2); e85766
  • Published Online: April 23, 2019
  • Article Type: Research Article
  • Received: October 26, 2018
  • Revised: January 29, 2019
  • Accepted: February 17, 2019
  • DOI: 10.5812/archcid.85766

To Cite: Mahmoudi Monfared A, Rezaei A, Poursina F, Faghri J. Detection of Genes Involved in Biofilm Formation in MDR and XDR Acinetobacter baumannii Isolated from Human Clinical Specimens in Isfahan, Iran, Arch Clin Infect Dis. Online ahead of Print ; 14(2):e85766. doi: 10.5812/archcid.85766.

Copyright © 2019, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Bardbari AM, Arabestani MR, Karami M, Keramat F, Alikhani MY, Bagheri KP. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microb Pathog. 2017;108:122-8. doi: 10.1016/j.micpath.2017.04.039. [PubMed: 28457900].
  • 2. Rezaei A, Fazeli H, Halaji M, Moghadampour M, Faghri J. Prevalence of metallobetalactamase producing Acinetobacter baumannii isolated from intensive care unit in tertiary care hospitals. Ann Ig. 2018;30(4):330-6. doi: 10.7416/ai.2018.2224. [PubMed: 29895050].
  • 3. Fallah F, Karimi A, Goudarzi M, Shiva F, Navidinia M, Jahromi MH, et al. Determination of integron frequency by a polymerase chain reaction-restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections. Microb Drug Resist. 2012;18(6):546-9. doi: 10.1089/mdr.2012.0073. [PubMed: 22816551].
  • 4. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254-63. doi: 10.1086/529198. [PubMed: 18444865].
  • 5. Navidinia M, Goudarzi M, Molaei Rameshe S, Farajollahi Z, Ebadi Asl P, Zaka Khosravi S, et al. Molecular characterization of resistance genes in MDR-ESKAPE pathogens. J Pure Appl Microbiol. 2017;11(2):779-92. doi: 10.22207/jpam.11.2.17.
  • 6. Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med. 2013;17(4):214-8. doi: 10.4103/0972-5229.118416. [PubMed: 24133328]. [PubMed Central: PMC3796899].
  • 7. Greene C, Vadlamudi G, Newton D, Foxman B, Xi C. The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control. 2016;44(5):e65-71. doi: 10.1016/j.ajic.2015.12.012. [PubMed: 26851196].
  • 8. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284(5418):1318-22. doi: 10.1126/science.284.5418.1318. [PubMed: 10334980].
  • 9. Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009;4(3):273-8. doi: 10.2217/fmb.09.5. [PubMed: 19327114]. [PubMed Central: PMC2724675].
  • 10. Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun. 2012;80(1):228-33. doi: 10.1128/IAI.05913-11. [PubMed: 22083703]. [PubMed Central: PMC3255684].
  • 11. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003;149(Pt 12):3473-84. doi: 10.1099/mic.0.26541-0. [PubMed: 14663080].
  • 12. Vijayakumar S, Rajenderan S, Laishram S, Anandan S, Balaji V, Biswas I. Biofilm formation and motility depend on the nature of the Acinetobacter baumannii clinical isolates. Front Public Health. 2016;4:105. doi: 10.3389/fpubh.2016.00105. [PubMed: 27252939]. [PubMed Central: PMC4877508].
  • 13. Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology. 2008;154(Pt 11):3398-409. doi: 10.1099/mic.0.2008/019471-0. [PubMed: 18957593].
  • 14. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974-6. doi: 10.1128/JCM.01021-06. [PubMed: 16891520]. [PubMed Central: PMC1594603].
  • 15. Patel JB. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute; 2017.
  • 16. Ghanbarzadeh Corehtash Z, Khorshidi A, Firoozeh F, Akbari H, Mahmoudi Aznaveh A. Biofilm formation and virulence factors among Pseudomonas aeruginosa isolated from burn patients. Jundishapur J Microbiol. 2015;8(10). e22345. doi: 10.5812/jjm.22345. [PubMed: 26587205]. [PubMed Central: PMC4644346].
  • 17. Ahmed OB, Dablool AS. Quality improvement of the DNA extracted by boiling method in gram negative bacteria. Int J Bioassays. 2017;6(4):5347-9. doi: 10.21746/ijbio.2017.04.004.
  • 18. Fallah F, Noori M, Hashemi A, Goudarzi H, Karimi A, Erfanimanesh S, et al. Prevalence of bla NDM, bla PER, bla VEB, bla IMP, and bla VIM genes among acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica (Cairo). 2014;2014:245162. doi: 10.1155/2014/245162. [PubMed: 25133013]. [PubMed Central: PMC4123593].
  • 19. Azizi O, Shahcheraghi F, Salimizand H, Modarresi F, Shakibaie MR, Mansouri S, et al. Molecular analysis and expression of bap gene in biofilm-forming multi-drug-resistant Acinetobacter baumannii. Rep Biochem Mol Biol. 2016;5(1):62-72. [PubMed: 28070537]. [PubMed Central: PMC5214686].
  • 20. Borer A, Gilad J, Smolyakov R, Eskira S, Peled N, Porat N, et al. Cell phones and Acinetobacter transmission. Emerg Infect Dis. 2005;11(7):1160-1. doi: 10.3201/eid1107.050221. [PubMed: 16032803]. [PubMed Central: PMC3371817].
  • 21. Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358(12):1271-81. doi: 10.1056/NEJMra070741. [PubMed: 18354105].
  • 22. Daef EA, Mohamad IS, Ahmad AS, El-Gendy SG, Ahmed EH, Sayed IM. Relationship between clinical and environmental isolates of Acinetobacter baumannii in assiut university hospitals. J Am Sci. 2013;9(11s):67-73.
  • 23. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K, et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns. 2012;38(8):1198-203. doi: 10.1016/j.burns.2012.04.008. [PubMed: 22579564].
  • 24. Sepahvand S, Doudi M, Davarpanah MA, Bahador A, Ahmadi M. Analyzing pmrA and pmrB genes in Acinetobacter baumannii resistant to colistin in Shahid Rajai Shiraz, Iran Hospital by PCR: First report in Iran. Pak J Pharm Sci. 2016;29(4 Suppl):1401-6. [PubMed: 27592491].
  • 25. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011;3(2):68-74. [PubMed: 22347585]. [PubMed Central: PMC3279807].
  • 26. Badmasti F, Siadat SD, Bouzari S, Ajdary S, Shahcheraghi F. Molecular detection of genes related to biofilm formation in multidrug-resistant Acinetobacter baumannii isolated from clinical settings. J Med Microbiol. 2015;64(Pt 5):559-64. doi: 10.1099/jmm.0.000058. [PubMed: 25813817].
  • 27. Liu H, Wu YQ, Chen LP, Gao X, Huang HN, Qiu FL, et al. Biofilm-related genes: Analyses in multi-antibiotic resistant Acinetobacter baumannii isolates from Mainland China. Med Sci Monit. 2016;22:1801-7. doi: 10.12659/MSM.898959. [PubMed: 27234982]. [PubMed Central: PMC4913728].
  • 28. Sung JY, Koo SH, Kim S, Kwon GC. Persistence of multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23 and bap for 5 years. J Microbiol Biotechnol. 2016;26(8):1481-9. doi: 10.4014/jmb.1604.04049. [PubMed: 27221112].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments